More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.

To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this link

To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html

The USD 3.7 billion (by 2030) financial opportunity within the encapsulated cell therapies and encapsulation technologies market has been analyzed across the following segments:
Type of licensing deal payment
Upfront payment
Milestone payment

Therapeutic area
Metabolic disorder
Neurological disorder
Ophthalmic disorder
Oncological disorder

Target disease indication
Ataxia telangiectasia
Breast cancer
Diabetes
Glaucoma
Head and neck cancer
Macular telangectasia
Pancreatic cancer
Parkinson's disease
Retinitis pigmentosa

Type of encapsulation material used
Alginate-based microcapsule
Cellulose hydrogel
Medical-grade plastic
Red blood cell

Key geographical region
North America
Europe
Asia-Pacific and rest of the world

The Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030 report features the following companies, which we identified to be key players in this domain:
ALTuCELL
Azellon Cell Therapeutics
Beta-Cell
Betalin Therapeutics
CellProtect Biotechnology
Diatranz Otsuka
Encellin
EryDel
Gloriana Therapeutics
Living Cell Technologies
MaxiVAX
Neurotech Pharmaceuticals
PharmaCyte Biotech
Semma Therapeutics
Sernova

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Encapsulated Cell Therapies and Encapsulation Technologies for Metabolic Disorders: Company Profiles

6. Encapsulated Cell Therapies and Encapsulation Technologies for Non-Metabolic Disorders: Company Profiles

7. Patent Analysis

8. Clinical Trial Analysis

9. Recent Partnerships

10. Funding and Investment Analysis

11. Grant Analysis

12. Potential Strategic Partners

13. Market Forecast

14. Conclusion

15. Executive Insights

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.